
1. OMICS. 2021 Nov;25(11):679-680. doi: 10.1089/omi.2021.0176. Epub 2021 Oct 25.

Pharmacogenomics for Clinical Trials of COVID-19 Medicines: Why Is This Important
Now?

Şardaş S(1), Özdemir V(2).

Author information: 
(1)Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istinye
University, Istanbul, Turkey.
(2)OMICS: A Journal of Integrative Biology, New Rochelle, New York, USA.

DOI: 10.1089/omi.2021.0176 
PMID: 34699259  [Indexed for MEDLINE]

